HIND

$1.77+0.57%visit website

Vyome Holdings, Inc

Market Cap

$12M

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.55

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

95.8

TTM to Jun 2026 · revenue

P/B

1.7

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	35	37	32	27	130
Cost of revenue	16.6	14.5	14.9	15.3	61.3
Gross profit	18.1	22.1	16.6	11.7	68.4
Research & development	40	378	666	507	1,591
Selling, general & administrative	844	996	478	365	2,683
Total operating expenses	8,592	1,377	1,147	874	11,990
Operating income	(8,574)	(1,355)	(1,130)	(863)	(11,922)
Interest expense	25.6	9.9	2.8	3.3	41.7
Net income	(8,434)	(1,225)	(963)	(686)	(11,308)
EPS (basic) ($)	(3.12)		(0.15)	(0.10)	—
EPS (diluted) ($)	(3.12)		(0.15)	(0.10)	—
Weighted avg. shares (basic)	2,758		6,690	7,019
Weighted avg. shares (diluted)	2,758		6,690

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 42 more quarters, back to Mar 2015, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 28, 2026 accepted 4:31 PM ET	5.02Officer / director change	Document SEC ↗
Aug 25, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
May 29, 2026 accepted 8:42 AM ET	2.02Earnings release	Document SEC ↗
Apr 29, 2026 accepted 4:16 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
Feb 25, 2026 accepted 4:15 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Feb 13, 2026 accepted 9:16 PM ET	7.01Reg FD disclosure	Document SEC ↗
Jan 28, 2026 accepted 9:00 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Dec 23, 2025 accepted 4:10 PM ET	1.01Material agreement	Document SEC ↗
Nov 19, 2025 accepted 5:21 PM ET	2.02Earnings release	Document SEC ↗
Oct 30, 2025 accepted 4:02 PM ET	5.07Shareholder vote	Document SEC ↗